Min Shi
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 13
- Cancer, Hypoxia, and Metabolism 12
- Cancer, Lipids, and Metabolism 10
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 18
- Molecular Biology top 2%
- RNA modifications and cancer 9
-
- Ferroptosis and cancer prognosis 12
- Gastric Cancer Management and Outcomes 8
- Immunology top 5%
- Immune cells in cancer 8
- Journals
- Journal of Clinical Oncology (4 papers)SHILAP Revista de lepidopterología (4 papers)ACS Nano (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Min Shi
156 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Cancer Research 2.1k
- Oncology 1.6k
- Molecular Biology 3.5k
- Pulmonary and Respiratory Medicine 1.6k
- Immunology 882
Countries citing papers authored by Min Shi
This map shows the geographic impact of Min Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Shi more than expected).
Fields of papers citing papers by Min Shi
This network shows the impact of papers produced by Min Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Shi. The network helps show where Min Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 12 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 61 | |
| 5 | 2023 | 13 | |
| 6 | 2023 | 50 | |
| 7 | 2023 | 15 | |
| 8 | 2021 | 38 | |
| 9 | 2021 | 23 | |
| 10 | 2021 | 17 | |
| 11 | 2020 | 13 | |
| 12 | 2020 | 44 | |
| 13 | Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signaturesbreakdown → | 2019 | 697 |
| 14 | 2019 | 40 | |
| 15 | 2018 | 6 | |
| 16 | 2018 | 29 | |
| 17 | 2018 | 1 | |
| 18 | Baicalin Improves DSS-Induced Colitis in Mice Via the TLRs/MyD88 Signaling Pathway | 2014 | 2 |
| 19 | 2013 | 98 | |
| 20 | Influence of Buguzhi Decoction on BDNF/TrkB and GAP-43 in the Hippocampus of Vascular Dementia Rats | 2011 | 1 |
About Min Shi
Min Shi is a scholar working on Cancer Research, Nephrology and Oncology, having authored 164 papers that have together received 6.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Cancer-related molecular mechanisms research (13 papers), Ferroptosis and cancer prognosis (12 papers), Cancer, Hypoxia, and Metabolism (12 papers), Cancer, Lipids, and Metabolism (10 papers), RNA modifications and cancer (9 papers), Gastric Cancer Management and Outcomes (8 papers) and Immune cells in cancer (8 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (1.6k citations) and Molecular Biology (3.5k citations). Min Shi has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Wangjun Liao, Yulin Liao, Jianping Bin, Rui Zhou, Dongqiang Zeng, Qiong Huang, Wanming He, Shuyi Zhang, Na Huang and Shumin Dong. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.